Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study

Survival in children with relapsed/refractory acute myeloid leukemia is unsatisfactory. Treatment consists of one course of fludarabine, cytarabine and liposomal daunorubicin, followed by fludarabine and cytarabine and stem-cell transplantation. Study ITCC 020/I-BFM 2009-02 aimed to identify the rec...

Descripción completa

Detalles Bibliográficos
Autores principales: van Eijkelenburg, Natasha K.A., Rasche, Mareike, Ghazaly, Essam, Dworzak, Michael N., Klingebiel, Thomas, Rossig, Claudia, Leverger, Guy, Stary, Jan, De Bont, Eveline S.J.M., Chitu, Dana A., Bertrand, Yves, Brethon, Benoit, Strahm, Brigitte, van der Sluis, Inge M., Kaspers, Gertjan J.L., Reinhardt, Dirk, Zwaan, C. Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119144/
https://www.ncbi.nlm.nih.gov/pubmed/29773602
http://dx.doi.org/10.3324/haematol.2017.187153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119144/
https://www.ncbi.nlm.nih.gov/pubmed/29773602
http://dx.doi.org/10.3324/haematol.2017.187153

Ejemplares similares